Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
35 (14%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Resolved | 2020-04-03 | 2020-05-14 | 110794 |
TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Resolved | 2020-06-25 | 2021-02-18 | 118957 |
TEVA-TRIAMTERENE/HCTZ | 25MG 50MG | TABLET | Resolved | 2023-08-17 | 2023-10-12 | 202200 |
TEVA-TRIMEL | 400MG 80MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1582 |
TEVA-TRIMEL | 40MG 8MG | SUSPENSION | Actual shortage | 2017-03-13 | 2017-10-13 | 1591 |
TEVA-TRIMEL | 40MG 8MG | SUSPENSION | Actual shortage | 2017-03-13 | 2017-10-13 | 1609 |
TEVA-TRYPTOPHAN | 1G | TABLET | Resolved | 2020-02-07 | 2020-03-26 | 105564 |
TEVA-TRYPTOPHAN | 500MG | TABLET | Resolved | 2020-02-07 | 2020-03-26 | 105570 |
TEVA-TRYPTOPHAN | 1G | TABLET | Resolved | 2021-06-17 | 2021-10-21 | 141119 |
TEVA-TRYPTOPHAN | 500MG | CAPSULE | Resolved | 2021-09-23 | 2022-05-19 | 146098 |
TEVA-TRYPTOPHAN | 500MG | TABLET | Resolved | 2023-10-05 | 2024-03-18 | 206383 |
TEVA-TRYPTOPHAN | 1G | TABLET | Resolved | 2024-01-11 | 2024-03-18 | 215713 |
TEVA-VALACYCLOVIR | 500MG | TABLET | Resolved | 2019-10-31 | 2020-03-05 | 97605 |
TEVA-VALACYCLOVIR | 500MG | TABLET | Resolved | 2024-02-15 | 2024-04-11 | 219674 |
TEVA-VALACYCLOVIR | 500MG | TABLET | Actual shortage | 2024-04-18 | 2024-05-03 | 225489 |
TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2017-08-02 | 2018-03-13 | 18033 |
TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2022-01-20 | 2022-06-16 | 153189 |
TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2023-04-27 | 2023-06-21 | 190683 |
TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2023-09-19 | 2023-10-26 | 204769 |
TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2023-11-16 | 2024-03-28 | 210440 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
TEVA-LENOLTEC NO. 1 | 300MG 8MG 15MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81362 |
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 |